Boehringer Ingelheim (United Kingdom)
- World rank, all time
- #27,392 of 42,892
- Rank in United Kingdom
- #1,460 of 2,253
- Research works
- 169 ▼ 50% vs 2013–17
- Citations
- 4.2k 25.0 per fractional work
- Top-10% rate
- 10.0% record average 16.5%
- Open access
- 38% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 6.2×. Every wedge is a field page.
- Veterinary 6.2×
- Medicine 3.6×
- Health Professions 2.9×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Chemistry 1.1×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Psychology 1.0×
- Agricultural and Biological Sciences 0.9×
- Economics, Econometrics and Finance 0.9×
- Immunology and Microbiology 0.9×
- Energy 0.7×
- Nursing 0.5×
- Mathematics 0.4×
- Business, Management and Accounting 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Engineering 0.0×
Which keywords describe research at Boehringer Ingelheim (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Heart Failure, Insulin Therapy, Clinical Guidelines, Type 2 Diabetes, Cardiovascular Outcomes, Glucose Control and Diagnosis.
- Risk Stratification
- Stroke Prevention
- Anticoagulant Therapy
- Pulmonary Drug Delivery
- TGF-ß
- Chemotherapy
- Guidelines
- Allergic Diseases
- Asthma
- Health Utility Measures
- Economic Evaluation
- COPD
- Primary Care
- Global Burden
- Inflammation
- Cardiovascular Outcomes
- Type 2 Diabetes
- Treatment
- Insulin Therapy
- Glycemic Control
- Epidemiology
- Heart Failure
- Clinical Guidelines
- Quality of Life
- Diagnosis
- Glucose Control
- Cardiovascular Disease
- Management
- Clinical Practice Guidelines
- Cost-effectiveness Analysis
- Genetics
- spirometry
- Clinical Trials
- Eosinophils
- Diabetes
- Fibrosis
- Inhaler Devices
- Diabetes Mellitus
- Catheter Ablation
- Atrial Fibrillation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology17▲ 2.5×33 topics
- Glycemic Control15▲ 65×4 topics
- Heart Failure15▲ 19×7 topics
- Insulin Therapy15▲ 78×3 topics
- Clinical Guidelines14▲ 27×5 topics
- Treatment13▲ 5.8×13 topics
- Quality of Life13▲ 5.5×12 topics
- Type 2 Diabetes12▲ 40×2 topics
- Diagnosis12▲ 7.1×12 topics
- Cardiovascular Outcomes12▲ 167×1 topic
- Glucose Control12▲ 167×1 topic
- Inflammation10▲ 2.6×25 topics
- Cardiovascular Disease10▲ 5.5×17 topics
- Global Burden10▲ 10×6 topics
- Management8▲ 5.8×7 topics
- Primary Care8▲ 11×11 topics
- Clinical Practice Guidelines7▲ 7.5×9 topics
- COPD7▲ 64×1 topic
- Cost-effectiveness Analysis7▲ 52×1 topic
- Economic Evaluation7▲ 32×2 topics
- Genetics7▲ 5.3×6 topics
- Health Utility Measures7▲ 52×1 topic
- spirometry7▲ 64×1 topic
- Asthma6▲ 30×2 topics
- Clinical Trials6▲ 6.1×9 topics
- Allergic Diseases6▲ 47×1 topic
- Eosinophils6▲ 47×1 topic
- Guidelines6▲ 7.8×5 topics
- Diabetes6▲ 6.7×7 topics
- Chemotherapy6▲ 4.7×12 topics
- Fibrosis5▲ 15×4 topics
- TGF-ß5▲ 16×4 topics
- Inhaler Devices4▲ 87×1 topic
- Pulmonary Drug Delivery4▲ 87×1 topic
- Diabetes Mellitus4▲ 11×4 topics
- Anticoagulant Therapy4▲ 22×2 topics
- Catheter Ablation4▲ 20×2 topics
- Stroke Prevention4▲ 20×2 topics
- Atrial Fibrillation4▲ 26×1 topic
- Risk Stratification4▲ 37×1 topic
Which research topics does Boehringer Ingelheim (United Kingdom) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Migraine and Headache Studies, Chronic Disease Management Strategies and Heart Failure Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
- 2 Migraine and Headache Studies Psychiatry and Mental health 2 works
- 3 Chronic Disease Management Strategies Epidemiology 2 works
- 4 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
- 5 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
- 6 Pneumonia and Respiratory Infections Epidemiology 0 works
- 7 Global Health Care Issues General Health Professions 0 works
- 8 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
- 9 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 10 Healthcare Systems and Reforms Finance 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (United Kingdom)'s research output changed?
Output in 2018–2022 was 50% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bracknell
- Hewlett-Packard (United Kingdom)
- Berkshire Healthcare NHS Foundation Trust
- Bracknell and Wokingham College
- 3M (United Kingdom)
- Panasonic (United Kingdom)
- Cadence Design Systems (United Kingdom)
- Building Services Research and Information Association
- BMW (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.